Zaderer, Viktoria
Dichtl, Stefanie
Bellmann Weiler, Rosa
Lass Flörl, Cornelia
Posch, Wilfried
Wilflingseder, Doris
Funding for this research was provided by:
Austrian Science Fund (P34070-B, P33510-B)
Article History
Received: 23 August 2022
Accepted: 5 October 2022
First Online: 31 October 2022
Change Date: 24 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12931-023-02326-4
Declarations
:
: Written informed consent was obtained from all donors of leftover nasopharyngeal/ oropharyngeal specimens and EDTA blood by the participating clinics. The Ethics Committee of the Medical University of Innsbruck (a copy is attached to the proposal, ECS1166/2020) approved the use of anonymized leftover specimens of COVID-19 patients for scientific purposes. All authors read and approved the final manuscript.
: The study was partly financially supported by Enzymatica AB. The funders had no influence on study design, analysis and data validation. The major part of the study was supported by the FWF, Enzymatica only provided several materials.